Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment
暂无分享,去创建一个
T. Biering-Sørensen | M. Metra | M. Cameli | C. Lombardi | A. Bonelli | M. Pagnesi | R. Inciardi | S. Solomon | M. Pagnesi
[1] S. Solomon,et al. Association of Left Atrial Structure and Function With Heart Failure in Older Adults. , 2022, Journal of the American College of Cardiology.
[2] S. Solomon,et al. Cardiac Structure and Function and Diabetes‐Related Risk of Death or Heart Failure in Older Adults , 2022, Journal of the American Heart Association.
[3] A. Tveit,et al. Left atrial function in male veteran endurance athletes with paroxysmal atrial fibrillation , 2021, European heart journal. Cardiovascular Imaging.
[4] P. Ponikowski,et al. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. , 2021, The New England journal of medicine.
[5] S. Solomon,et al. Association Between Angiotensin Receptor–Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction , 2021, Circulation. Heart failure.
[6] S. Solomon,et al. Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans , 2021, European journal of heart failure.
[7] P. Faggiano,et al. Stage A Heart Failure: Modern Strategies for an Effective Prevention. , 2021, Heart failure clinics.
[8] A. Coats,et al. Individual patient data meta‐analysis of the effects of the CARILLON® mitral contour system , 2020, ESC heart failure.
[9] J. McMurray,et al. Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF) , 2020, Circulation.
[10] P. Ponikowski,et al. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. , 2020, The New England journal of medicine.
[11] P. Ponikowski,et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. , 2020, The New England journal of medicine.
[12] G. Cho,et al. Left Atrial Strain Measurement: A New Normal for Diastolic Assessment? , 2020, JACC. Cardiovascular imaging.
[13] P. Donnan,et al. Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial , 2020, Diabetes Care.
[14] J. Kalman,et al. The Atrium and Embolic Stroke: Myopathy Not Atrial Fibrillation as the Requisite Determinant? , 2020, JACC. Clinical electrophysiology.
[15] B. Borlaug,et al. Left atrial myopathy in heart failure with preserved ejection fraction , 2020, European journal of heart failure.
[16] Michael E. Hall,et al. Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta‐analysis , 2020, European journal of heart failure.
[17] R. Nishimura,et al. Functional mitral regurgitation and left atrial myopathy in heart failure with preserved ejection fraction , 2020, European journal of heart failure.
[18] M. Guazzi,et al. Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics , 2019, European journal of heart failure.
[19] S. Solomon,et al. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation , 2019, European journal of heart failure.
[20] S. Goldberg,et al. The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation. , 2019, JACC. Heart failure.
[21] S. Solomon,et al. Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction. , 2019, JAMA.
[22] Akshay S. Desai,et al. Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. , 2019, JAMA.
[23] J. Jalife,et al. Atrial Myopathy , 2019, JACC. Basic to translational science.
[24] M. Cameli,et al. Prognosis and Risk Stratification of Patients With Advanced Heart Failure (from PROBE). , 2019, The American journal of cardiology.
[25] M. Emdin,et al. The analysis of left atrial function predicts the severity of functional impairment in chronic heart failure: The FLASH multicenter study. , 2019, International journal of cardiology.
[26] G. Mancia,et al. Left atrial function in elite athletes: A meta‐analysis of two‐dimensional speckle tracking echocardiographic studies , 2019, Clinical cardiology.
[27] Erwan Donal,et al. Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[28] F. D’Ascenzi,et al. Prognostic value of left atrial strain in patients with moderate asymptomatic mitral regurgitation , 2019, The International Journal of Cardiovascular Imaging.
[29] G. Hindricks,et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.
[30] E. Braunwald,et al. Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure , 2019, The New England journal of medicine.
[31] B. Popescu,et al. Left Atrial Dysfunction as an Independent Correlate of Heart Failure Symptoms in Patients With Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[32] A. Aidietis,et al. Left atrial strain - an early marker of left ventricular diastolic dysfunction in patients with hypertension and paroxysmal atrial fibrillation , 2018, Cardiovascular Ultrasound.
[33] K. Hirata,et al. Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure , 2018, Cardiovascular Diabetology.
[34] S. Nagueh,et al. Changes in Left Atrial Function After Transcutaneous Mitral Valve Repair. , 2018, The American journal of cardiology.
[35] B. Gerber,et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging , 2018, European heart journal cardiovascular Imaging.
[36] M. Galderisi,et al. Echocardiographic advances in hypertrophic cardiomyopathy: Three‐dimensional and strain imaging echocardiography , 2018, Echocardiography.
[37] E. Foster,et al. Impact of the MitraClip Procedure on Left Atrial Strain and Strain Rate , 2018, Circulation. Cardiovascular imaging.
[38] A. Boyd,et al. Left atrial function: evaluation by strain analysis. , 2018, Cardiovascular diagnosis and therapy.
[39] D. Burkhoff,et al. Reverse remodelling and myocardial recovery in heart failure , 2018, Nature Reviews Cardiology.
[40] L. Jordaens,et al. Catheter Ablation for Atrial Fibrillation with Heart Failure , 2018, The New England journal of medicine.
[41] J. Mancio,et al. Impaired Left Atrial Strain as a Predictor of New-onset Atrial Fibrillation After Aortic Valve Replacement Independently of Left Atrial Size. , 2017, Revista espanola de cardiologia.
[42] H. Kamel,et al. Atrial cardiopathy: a mechanism of cryptogenic stroke , 2017, Expert review of cardiovascular therapy.
[43] J. Daubert,et al. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial. , 2017, JACC. Heart failure.
[44] T. Marwick,et al. Normal Ranges of Left Atrial Strain by Speckle‐Tracking Echocardiography: A Systematic Review and Meta‐Analysis , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[45] W. Abhayaratna,et al. Left Atrial Reverse Remodeling: Mechanisms, Evaluation, and Clinical Significance. , 2017, JACC. Cardiovascular imaging.
[46] Piotr Ponikowski,et al. Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial , 2016, The Lancet.
[47] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.
[48] S. Solomon,et al. Abstract 19108: Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Atrial Structure and Function in Chronic Heart Failure (COSMIC-HF) , 2016 .
[49] A. Esen,et al. Left atrial remodeling in patients undergoing percutaneous mitral valve repair with the MitraClip system: an advanced echocardiography study , 2016, Echocardiography.
[50] S. Solomon,et al. Clinical Implications of Complete Left-Sided Reverse Remodeling With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy. , 2016, Journal of the American College of Cardiology.
[51] A. Kobori,et al. Associations of residual left ventricular and left atrial remodeling with clinical outcomes in patients after aortic valve replacement for severe aortic stenosis. , 2016, Journal of cardiology.
[52] I. V. Van Gelder,et al. Atrial reverse remodelling is associated with outcome of cardiac resynchronization therapy. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[53] G. Boriani,et al. Effect of Cardiac Resynchronization Therapy on Left Atrial Size and Function as Expressed by Speckle Tracking 2-Dimensional Strain. , 2016, The American journal of cardiology.
[54] Sanjiv J. Shah,et al. Constitutive Expression of a Dominant-Negative TGF-β Type II Receptor in the Posterior Left Atrium Leads to Beneficial Remodeling of Atrial Fibrillation Substrate. , 2016, Circulation research.
[55] W. Abhayaratna,et al. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[56] Hung-Hao Lee,et al. Prognostic role of left atrial strain and its combination index with transmitral E-wave velocity in patients with atrial fibrillation , 2016, Scientific Reports.
[57] S. Solomon,et al. Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study. , 2016, Circulation. Heart failure.
[58] T. Marwick,et al. Functional and Anatomic Responses of the Left Atrium to Change in Estimated Left Ventricular Filling Pressure. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[59] Sanjiv J. Shah,et al. Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone , 2015, Circulation. Heart failure.
[60] R. Mahajan,et al. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study. , 2015, Journal of the American College of Cardiology.
[61] Christopher X. Wong,et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). , 2015, Journal of the American College of Cardiology.
[62] W. Haverkamp,et al. Normal values and clinical relevance of left atrial myocardial function analysed by speckle-tracking echocardiography: multicentre study. , 2015, European heart journal cardiovascular Imaging.
[63] V. Melenovský,et al. Left Atrial Remodeling and Function in Advanced Heart Failure With Preserved or Reduced Ejection Fraction , 2015, Circulation. Heart failure.
[64] G. Pedrizzetti,et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[65] R. Mahajan,et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. , 2014, Journal of the American College of Cardiology.
[66] Jeroen J. Bax,et al. Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation , 2014, Heart.
[67] M. Chung,et al. Global left atrial strain in the prediction of sinus rhythm maintenance after catheter ablation for atrial fibrillation. , 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[68] S. Solomon,et al. Left Atrium in Heart Failure With Preserved Ejection Fraction: Structure, Function, and Significance , 2014, Circulation. Heart failure.
[69] S. Nagueh,et al. Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. , 2014, Journal of cardiac failure.
[70] N. Ozdemir,et al. Atrial longitudinal strain parameters predict left atrial reverse remodeling after mitral valve surgery: a speckle tracking echocardiography study , 2014, The International Journal of Cardiovascular Imaging.
[71] G. Grassi,et al. Effects of bariatric surgery on cardiac structure and function: a systematic review and meta-analysis. , 2014, American journal of hypertension.
[72] J. Maessen,et al. Improvement of left atrial function and left atrial reverse remodeling after surgical treatment of atrial fibrillation. , 2014, Annals of cardiothoracic surgery.
[73] S. Inci,et al. Assessment of effect of irbesartan and nebivolol on the left atrium volume and deformation in the patients with mild-moderate hypertension. , 2014, European review for medical and pharmacological sciences.
[74] Ji Eun Song,et al. Progressive Dilation of the Left Atrium and Ventricle after Acute Myocardial Infarction Is Associated with High Mortality , 2013, Korean circulation journal.
[75] Christopher X. Wong,et al. Aortic Stiffness in Lone Atrial Fibrillation: A Novel Risk Factor for Arrhythmia Recurrence , 2013, PloS one.
[76] M. O'Neill,et al. Catheter ablation of atrial fibrillation in heart failure. , 2013, Heart failure clinics.
[77] M. Henein,et al. Left atrial remodelling in patients undergoing transcatheter aortic valve implantation: a speckle-tracking prospective, longitudinal study , 2013, The International Journal of Cardiovascular Imaging.
[78] S. Yusuf,et al. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. , 2013, International journal of cardiology.
[79] R. Wachter,et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. , 2013, JAMA.
[80] Jong Chun Park,et al. Abstract. The remodeling of gap junctions may affect their conduction properties and contribute to the maintenance of atrial fibrillation. The significance of the role of angiotensin‐II receptor blockers (ARBs) in upstream therapy is not clear , 2013 .
[81] S. Solomon,et al. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial , 2012, The Lancet.
[82] A. Goette,et al. Physiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation. , 2012, Cardiovascular therapeutics.
[83] Prashanthan Sanders,et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. , 2012, Heart rhythm.
[84] Jeroen J. Bax,et al. Imaging for atrial fibrillation. , 2012, Current problems in cardiology.
[85] M. Luaces,et al. Anatomical and functional alterations of the heart in morbid obesity. Changes after bariatric surgery. , 2012, Revista espanola de cardiologia.
[86] R. McKelvie,et al. Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction , 2011, Circulation.
[87] S. Fröhling,et al. Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. , 2011, Journal of the American College of Cardiology.
[88] Paul J. Wang,et al. Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). , 2011, Journal of the American College of Cardiology.
[89] B. Bozkurt,et al. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). , 2011, Journal of cardiac failure.
[90] Niels Voigt,et al. Recent advances in the molecular pathophysiology of atrial fibrillation. , 2011, The Journal of clinical investigation.
[91] T. Marwick,et al. Atrial strain rate is a sensitive measure of alterations in atrial phasic function in healthy ageing , 2011, Heart.
[92] J. Seward,et al. Left atrial function: physiology, assessment, and clinical implications. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[93] S. Hunt,et al. Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study. , 2011, Journal of the American College of Cardiology.
[94] L. Fusini,et al. Left atrial reverse remodeling and functional improvement after mitral valve repair in degenerative mitral regurgitation: a real-time 3-dimensional echocardiography study. , 2011, American heart journal.
[95] Jeroen J. Bax,et al. Left atrial strain predicts reverse remodeling after catheter ablation for atrial fibrillation. , 2011, Journal of the American College of Cardiology.
[96] M. Kayrak,et al. The effects of spironolactone on atrial remodeling in patients with preserved left ventricular function after an acute myocardial infarction: a randomized follow-up study , 2010, Coronary artery disease.
[97] T. Trikalinos,et al. Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. , 2010, Journal of the American College of Cardiology.
[98] Y. Kim,et al. Left atrial remodelling in patients with successful percutaneous mitral valvuloplasty: determinants and impact on long-term clinical outcome , 2010, Heart.
[99] Joshua J. E. Blauer,et al. Left Atrial Strain and Strain Rate in Patients With Paroxysmal and Persistent Atrial Fibrillation: Relationship to Left Atrial Structural Remodeling Detected by Delayed-Enhancement MRI , 2010, Circulation. Cardiovascular imaging.
[100] The Impact of Catheter Ablation on the Dynamic Function of the Left Atrium in Patients with Atrial Fibrillation: Insights from Four‐Dimensional Computed Tomographic Images , 2010, Journal of cardiovascular electrophysiology.
[101] D. Phelan,et al. Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. , 2009, Journal of the American College of Cardiology.
[102] Y. Takeyama,et al. Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats , 2009, Hypertension Research.
[103] D. Ross,et al. Impact of Mild Hypertension on Left Atrial Size and Function , 2009, Circulation. Cardiovascular imaging.
[104] H. Uno,et al. Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. , 2008, European heart journal.
[105] C. Lavie,et al. Clinical implications of left atrial enlargement: a review. , 2009, The Ochsner journal.
[106] M. Whooley,et al. Usefulness of left atrial volume index to predict heart failure hospitalization and mortality in ambulatory patients with coronary heart disease and comparison to left ventricular ejection fraction (from the Heart and Soul Study). , 2008, The American journal of cardiology.
[107] Warren J Manning,et al. Left atrial function and scar after catheter ablation of atrial fibrillation. , 2008, Heart rhythm.
[108] Left Atrial Contractility is Preserved After Successful Circumferential Pulmonary Vein Ablation in Patients with Atrial Fibrillation , 2008, Journal of cardiovascular electrophysiology.
[109] Ze-Zhou Song. Noninvasive Assessment of Left Atrial Function by Strain Rate Imaging in Patients with Hypertension: A Possible Beneficial Effect of Renin-Angiotensin System Inhibition on Left Atrial Function , 2008, Hypertension Research.
[110] M. Anselmino,et al. Effects of Bariatric Surgery on Early Myocardial Alterations in Adult Severely Obese Subjects , 2007, Cardiology.
[111] B. Popescu,et al. Left atrial remodelling early after mitral valve repair for degenerative mitral regurgitation , 2007, Heart.
[112] L. Zhang,et al. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs , 2007, Basic Research in Cardiology.
[113] M. Yoon,et al. Impact of myocardial perfusion on left atrial remodeling following primary angioplasty for acute myocardial infarction , 2006, Coronary artery disease.
[114] J. Olgin,et al. Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure , 2006, Circulation.
[115] James B Seward,et al. Left atrial size: physiologic determinants and clinical applications. , 2006, Journal of the American College of Cardiology.
[116] S. Nattel,et al. Kir3-Based Inward Rectifier Potassium Current: Potential Role in Atrial Tachycardia Remodeling Effects on Atrial Repolarization and Arrhythmias , 2006, Circulation.
[117] A. Terzic,et al. Bioenergetic protection of failing atrial and ventricular myocardium by vasopeptidase inhibitor omapatrilat. , 2006, American journal of physiology. Heart and circulatory physiology.
[118] J. Seward,et al. Effects of quinapril on left atrial structural remodeling and arterial stiffness. , 2006, The American journal of cardiology.
[119] F. Mohr,et al. ACE–inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation , 2006, Basic Research in Cardiology.
[120] E. Vicaut,et al. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. , 2005, European heart journal.
[121] Jeroen J. Bax,et al. MRI to Evaluate Left Atrial and Ventricular Reverse Remodeling After Restrictive Mitral Annuloplasty in Dilated Cardiomyopathy , 2005, Circulation.
[122] P. Byers,et al. Effects of weight loss after gastric bypass on right and left ventricular function assessed by tissue Doppler imaging. , 2005, The American journal of cardiology.
[123] M. Nieminen,et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. , 2005, Journal of the American College of Cardiology.
[124] Douglas W Mahoney,et al. Diastolic dysfunction and left atrial volume: a population-based study. , 2005, Journal of the American College of Cardiology.
[125] A. Mattioli,et al. Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan. , 2004, International journal of cardiology.
[126] L. Tavazzi,et al. Left atrium remodeling after acute myocardial infarction (results of the GISSI-3 Echo Substudy). , 2004, The American journal of cardiology.
[127] K. Arakawa,et al. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. , 2003, Journal of the American College of Cardiology.
[128] A. Ducharme,et al. Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials , 2003, Circulation.
[129] S. Nattel,et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. , 2002, Cardiovascular research.
[130] K. Arakawa,et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. , 2000, Circulation.
[131] K. Karason,et al. Effects of obesity and weight loss on cardiac function and valvular performance. , 1998, Obesity research.
[132] P. Toutouzas,et al. Effects of antihypertensive therapy on left atrial function. , 1996, Journal of human hypertension.
[133] W. C. Awe,et al. The Syndrome of Severe Mitral Regurgitation with Normal Left Atrial Pressure , 1963, Circulation.